Last Updated on March 20, 2025 by The Health Master
USFDA Approval
The United States Food and Drug Administration approval (USFDA approval) has been granted to Zydus Lifesciences to manufacture and distribute Ketoconazole Shampoo, 2%.
This development paves the way for Zydus to enter a lucrative market, directly competing with the reference listed drug (RLD), Nizoral Shampoo, 2%.
This USFDA approval is a regulatory milestone as well as a strategic move into the high-demand dermatological market.
Targeting Common Skin Conditions
Ketoconazole shampoo is an antifungal medicine used to treat seborrheic dermatitis, which is commonly known as dandruff.
Ketoconazole is also effective against other fungal infections of the skin, e.g., tinea versicolor.
The Ketoconazole shampoo having 2% concentration is widely known for its safety and efficacy.
This approval allows Zydus to provide a more accessible and potentially cost-effective alternative for patients suffering from these prevalent conditions.
Key Applications:
- Dandruff (Seborrheic Dermatitis)
- Tinea Versicolor
- Other fungal skin infections
Manufacturing in Ahmedabad
The manufacturing of Ketoconazole shampoo will be done at Zydus Lifesciences’ manufacturing facility situated in Changodar, Ahmedabad, Gujarat.
This manufacturing facility has advanced manufacturing techniques that adhere to stringent quality control standards laid down by the regulatory authorities.
Q: What is the use of Ketoconazole shampoo?
A: Ketoconazole shampoo is mainly used to treat dandruff and other fungal infections of the skin.
Q: Where will Zydus Lifesciences manufacture the shampoo?
A: At their topical manufacturing site in Changodar, Ahmedabad.
Q: How large is the market for Ketoconazole shampoo in the US?
A: According to IQVIA MAT January 2025, the annual sales are $68.89 million.
Disclaimer: This article contains information obtained from the source mentioned below. Our team made changes in the format to rewrite and present the news or article in a unique format.
Disclaimer: The information we have provided is for general knowledge and for informational purpose only and it cannot be treated as medical advice. Always consult your doctor for any health issues and / or for the treatment of the same. The Health Master does not claim responsibility for this information.
USFDA approval granted for first Nicotine Pouches
USFDA approval granted for this Genetic Disorder drug
USFDA approval granted for Latanoprost Ophthalmic Solution
USFDA approval granted for Sitagliptin and Metformin Hydrochloride Tablets
USFDA approval granted for Medical Device for heart condition
USFDA approval granted for Diltiazem Hydrochloride extended-release capsules
India: 11th in Global Pharma Exports with Quality and Transparency
CDSCO issues new Export NOC System: Details
West Bengal into action against counterfeit drugs in the state
USFDA inspection concluded at JB Chemicals and Pharma Gujarat
NSQ Drug: New Guidelines Proposed
Govt invites Pharma MedTech companies for funding: Apply now
Strengthen State Drug Testing Laboratories: DCGI
USFDA issues Warning Letter to Granules India over these Deficiencies
CM Haryana Honors FDA Haryana Team
CDSCO approval granted for Durvalumab for Limited-Stage SCLC in India
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
